Bio-Techne (TECH) The 44th Annual William Blair Growth Stock Conference summary

Mission and sustainability

• Mission centers on improving quality of life by advancing science and medicine, with a vision to unlock scientific possibilities together.

• Published third corporate sustainability report, with enhanced greenhouse gas monitoring and a focus on diversity and inclusion.

• Employees actively volunteer, and governance is overseen by a board with deep scientific and business expertise.

Business overview and market positioning

• Operates with over 3,000 employees across 35 global locations, generating $1.1 billion in annual revenue.

• 81% of revenue comes from consumables, with two main segments: protein sciences and diagnostics/genomics.

• Protein sciences account for 74% of revenue, diagnostics/genomics for 26%; pharma/biopharma is the largest end market at 50%.

• Core products address a $6 billion market with about 10% share, while four growth verticals target large, fast-growing markets.

Strategic pillars and innovation

• Strategic focus on people, leveraging core business, and building growth verticals in high-potential markets.

• Emphasis on innovation, with a CTO-led portfolio and a strong product pipeline.

• 19 acquisitions in 10 years have expanded offerings and integrated new technologies.

• Customer-centric approach, leveraging e-commerce platforms.